Weekly Recap | Revolution Medicines +0.81%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:37 AMRVMD+0.50%
Weekly Recap | Roche -4.04%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:34 AMRHHBY+2.89%
Weekly Recap | Lexicon Pharma +1.39%, consensus target above spotWeekly Review·Oct 3, 2026 at 07:11 AMLXRX+0.57%
Weekly Recap | Eli Lilly -3.43%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:08 AMLLY+2.70%LLYX+5.33%
Weekly Recap | Corcept Therap +0.11%, a choppy week ends higherWeekly Review·Oct 3, 2026 at 06:34 AMCORT+0.03%
